戻る Agenda
Redefining the Site Investigator's Experience
Session Chair(s)
Dan Milam, MBA
Vice President, Global Engagement
Society for Clinical Research Sites, United States
Knowledgeable site investigators are essential to conducting successful clinical trials. However, data suggest that administrative, financial, and logistical burdens associated with leading clinical trials are causing investigators to abandon clinical research after just one study (i.e “one-and-done”). Without a sufficient pool of experienced site investigators, US-based clinical trials are likely to become less efficient and more costly, ultimately threatening timely patient access to safe and effective therapies.
This forum will discuss actionable, evidence-based recommendations for strengthening and growing the site investigator community. This, in turn, will help to ensure the long-term sustainability of a US clinical trials enterprise capable of meeting the needs of patients and care providers.
Learning Objective : Describe factors that influence investigators’ decisions to leave or remain in clinical research practice; Initiate an informed discussion of the challenges to, and strategies for, ensuring an adequate investigator workforce; Discuss practical, action-based recommendations that can support the engagement, training, and retention of qualified site investigators.
Speaker(s)
Bullseye! Hitting the Mark from Long Distance: Partnering with Sites to Better Plan for Study Conduct in Feasibility
Earl Seltzer, MBA
CTI, United States
Senior Director, Partnerships and Innovation
Update on Redefining the Site Investigator Experience
Lisa Bartoli Moneymaker
Saama, United States
Chief Technology Officer/Chief Product Officer
Foundation Blocks for a Successful Investigator Site
Kaitlin Malone
Amgen, Inc., United States
Clinical Trial Oversight Manager